122.41 -2.07 (-1.66%)

74.11% Fall from 52W High

1.6M NSE+BSE Volume

High vol. this week

NSE 13 Mar, 2025 3:31 PM (IST)



Board Meetings - Sun Pharma Advanced Research Company Ltd.

The latest board meeting for Sun Pharma Advanced Research Company Ltd. took place on 10 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
10 Feb 2025 Quarterly Results -
04 Nov 2024 Quarterly Results -
05 Aug 2024 Quarterly Results -
24 May 2024 Audited Results -
05 Feb 2024 Quarterly Results -
06 Nov 2023 Quarterly Results -
07 Aug 2023 Quarterly Results -
22 May 2023 Audited Results & Others To consider Fund Raising
13 Feb 2023 Quarterly Results -
07 Nov 2022 Quarterly Results -
08 Aug 2022 Quarterly Results & Others Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
17 May 2022 Audited Results -
04 Feb 2022 Quarterly Results -
01 Nov 2021 Quarterly Results -
01 Sep 2021 Others inter alia, to consider and approve / evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
26 Jul 2021 Quarterly Results -
17 May 2021 Audited Results -
12 May 2021 Others Inter alia, to consider and evaluate proposals for raising of funds in one or more tranches by way of issue of Equity Shares or Securities/ Warrants convertible into Equity shares of the Company.
08 Feb 2021 Quarterly Results -
09 Nov 2020 Quarterly Results -
04 Aug 2020 Quarterly Results -
02 Jun 2020 Audited Results -
31 Jan 2020 Quarterly Results -
04 Nov 2019 Quarterly Results -
29 Jul 2019 Quarterly Results -
07 May 2019 Audited Results -
04 Feb 2019 Quarterly Results -
29 Oct 2018 Quarterly Results -
30 Jul 2018 Quarterly Results -
08 May 2018 Audited Results -
29 Jan 2018 Quarterly Results -
27 Oct 2017 Quarterly Results -
05 Aug 2017 Quarterly Results -
14 Jul 2017 Others Allotted 1,51,51,515 Warrants at a price (including the warrant subscription price and the warrant exercise price) of ` 330/- each.
05 May 2017 Others -
27 Jan 2017 Quarterly Results -
28 Oct 2016 Quarterly Results -
29 Jul 2016 Quarterly Results -
06 May 2016 Audited Results -
05 Mar 2016 Others To fix the Issue Price, Issue Size, Rights Entitlement Ratio, Fractional Entitlement & Record Date / Book Closure Dates for determining eligibility of the shareholders.
03 Feb 2016 Quarterly Results -
04 Nov 2015 Quarterly Results & Others approved the re-appointment of Mr. Sudhir Valia as the Director & CFO of the Company, who retires as a CFO on December 31, 2015,
01 Aug 2015 Quarterly Results -
12 May 2015 Rights Issue To consider the issue of equity shares of Re.1 each of the Company by way of rights issue for raising the funds for the Company.
05 May 2015 Audited Results -
30 Jan 2015 Quarterly Results -
31 Oct 2014 Quarterly Results -
31 Jul 2014 Quarterly Results -
03 May 2014 Audited Results -
01 Feb 2014 Quarterly Results -
29 Oct 2013 Quarterly Results -
30 Jul 2013 Quarterly Results -
14 May 2013 Audited Results -
24 Jan 2013 Quarterly Results -
27 Oct 2012 Quarterly Results -
31 Jul 2012 Quarterly Results -
02 May 2012 Audited Results -
01 Feb 2012 Quarterly Results -
24 Oct 2011 Quarterly Results -
08 Aug 2011 Quarterly Results -
07 May 2011 Audited Results -
01 Feb 2011 Quarterly Results -
21 Oct 2010 Quarterly Results -
24 Jul 2010 Quarterly Results -
22 May 2010 Audited Results -
23 Jan 2010 Quarterly Results -
24 Oct 2009 Quarterly Results -
20 Jul 2009 Quarterly Results -
23 May 2009 Audited Results -
24 Jan 2009 Quarterly Results -
27 Oct 2008 Quarterly Results -
29 Jul 2008 Quarterly Results -
14 May 2008 Audited Results -
24 Jan 2008 Quarterly Results -
27 Oct 2007 Quarterly Results -
23 Jul 2007 Quarterly Results -